Urinary Incontinence
Conditions
Interventions
An assistant researcher not involved in other stages of the research will randomize the participants into two groups: a control group and the intervention group. Randomization will be performed throug
E02.760.169.063.500.387
Sponsors
Faculdade de Medicina de Ribeirão Preto
Centro de Pesquisa Oncologica
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age group older than 18 years; Clinical staging I to III of pelvic gynecological cancer; Having undergone surgery, radiotherapy, and/or brachytherapy; Have urinary incontinence; Do not present any orthopedic or neurological limitations that prevent the practice of the rehabilitation program; Not being under physiotherapeutic treatment.
Exclusion criteria
Exclusion criteria: Withdrawal of the informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. The primary outcome of the study is the prevalence of urinary incontinence assessed through the question "How often do you lose urine?" being: 0- never, 1- once a week at least, 2- two or three times a week, 3- once a day, 4- several times a day and 5- all the time from the “International Consultation on Incontinence” questionnaire Questionnaire - Short Form (ICIQ-SF)." It is expected to find an improvement in the prevalence of urinary incontinence in the intervention group compared to the control group. | — |
Secondary
| Measure | Time frame |
|---|---|
| 2. The severity and impact of urinary incontinence on quality of life assessed by the questionnaire score "International Consultation on Incontinence Questionnaire – Short Form (ICIQ-SF)." and with that, a score that can range from 0 (when there is no report of urinary loss, with no impact on quality of life) and 21 greater impacts on quality of life and on the severity of urinary incontinence is obtained. 3. Sexual function assessed through the Female Sexual Function Index (FSFI) questionnaire, this questionnaire consists of 19 questions grouped into six areas: desire, excitement, lubrication, orgasm, satisfaction, and pain. The sexual function score at the end of the analysis can range from 2 to 36 points, and the higher the score obtained, the better the woman's sexual function. 4. Dyspareunia will be used as the score on the numerical scale from 0 to 10 where the end of the scale, "no pain" and the other "worst imaginable pain". 5. Self-esteem will be assessed by the Rosemberg self-esteem scale, the total score varies from 10 to 40 points, it is understood that the higher the value reached by the woman on the scale, the better her self-esteem. 6. Pain will be used to score the numerical scale from 0 to 10, where the ends of the scale "no pain" and the other "worst imaginable pain" and its location by a diagram of the body to identify the topography of pain. 7. Anal incontinence will be assessed by the Fecal Incontinence Quality of Life (FIQL) questionnaire, this questionnaire contains 29 questions, which allow the calculation of impact scores on quality of life in four scales: lifestyle, behavior, depression, and embarrassment. The lower the score on each scale, whose score can range from 1 to 5, the lower the functional status of quality of life. 8. The consistency of the stools will be according to the Bristol scale. 9. Vaginal stenosis by means of vaginal dilators containing 8 dilators, the smallest dilator has a diameter of 1.0 cm and length 6.5 cm an | — |
Countries
Brazil
Contacts
Public ContactTatiana Fretta
Outcome results
None listed